1987
DOI: 10.1136/bmj.295.6613.1655
|View full text |Cite
|
Sign up to set email alerts
|

Paget's disease of the orbit: before and after APD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

1990
1990
2011
2011

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 0 publications
0
2
0
1
Order By: Relevance
“…Aminohydroxypropylidene bisphosphonate and zoledronic acid (a potent bisphosphonate) were successfully used to treat patients who developed optic neuropathy and diplopia due to compression of cranial nerves (Buckler et al, 1987;Pane, 2007). In our patient, it was a localized disease with no compressive complications, and the diagnosis was not confirmatory before pathology report.…”
Section: Commentmentioning
confidence: 53%
See 1 more Smart Citation
“…Aminohydroxypropylidene bisphosphonate and zoledronic acid (a potent bisphosphonate) were successfully used to treat patients who developed optic neuropathy and diplopia due to compression of cranial nerves (Buckler et al, 1987;Pane, 2007). In our patient, it was a localized disease with no compressive complications, and the diagnosis was not confirmatory before pathology report.…”
Section: Commentmentioning
confidence: 53%
“…The bony orbital disorder that affects posterior 2. aspects of the greater or lesser wings of the sphenoid bone and anterior clinoid process, causing narrowing of the superior orbital fissure and optic canal, with subsequent proptosis, limitation of eye movement, and optic neuropathy (Eretto et al, 1984;Buckler et al, 1987;Kheterpal et al, 1994;Miller at al., 1999). Skull base Paget disease may cause compressive sixth nerve palsy (Pane, 2007).…”
Section: Introductionmentioning
confidence: 98%
“…Non sono stati eseguiti studi specificatamente disegnati a valutare l'efficacia dei bisfosfonati nel prevenire le deformità scheletriche. È stata documentata in alcuni casi una riduzione delle deformità facciali dopo completa normalizzazione del turnover osseo (33,34). Malgrado la mancanza di dati controllati è raccomandabile sottoporre a terapia medica pazienti affetti da MdP con interessamento del cranio e dei segmenti scheletrici sottoposti a maggior carico meccanico (arti inferiori, bacino, rachide lombare).…”
Section: Deformità Scheletricheunclassified